Clinical Trials in Houston

Showing 9821-9840 of 13,620 trials

Iressa Study in Patients With Salivary Gland Cancer

NCT00509002

The goal of this clinical research study is to learn if ZD1839 (Iressa®, gefitinib can help to shrink or slow the growth of advanced, recurrent, or metastatic salivary gland cancer. The safety of this drug will also be studied.

Salivary Gland Cancer

M.D. Anderson Cancer Center37 participantsStarted May 2004

Houston, Texas, United States

UNKNOWN< 1 mile

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

NCT03062033

Prospective study to quantify the prevalence of possible tardive dyskinesia (TD) in outpatient psychiatry practices in the United States (US), as well as to describe the associated disease burden in a cohort of patients with one or more psychiatric disorders and a cumulative lifetime exposure to antipsychotic medication of three months or more.

Tardive Dyskinesia

Neurocrine Biosciences70 participantsStarted Apr 2017

Little Rock, Arkansas, United States • Anaheim, California, United States • Anaheim, California, United States +31 more locations

Iressa Study in Patients With Salivary Gland Cancer

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Find Trials by Condition in Houston

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors

Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Proof of Concept (POC) in Patients With Ischaemic Stroke

Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease